Full Cancer & Heart Screening

020 7580 3145 | 020 7323 9292

Book An Appointment

Samples collected for blood tests are analysed in a lab for signs of cancer. The samples may show cancer cells, proteins or other substances made by the cancer. Blood tests can also give your doctor an idea of how well your organs are functioning and if they’ve been affected by cancer.

Tumour markers are chemicals made by tumour cells that can be detected in your blood. But tumour markers are also produced by some normal cells in your body, and levels may be significantly elevated in noncancerous conditions.

Female Package

CA 19-9 Stomach, Colorectal, Gastrointestinal, Pancreas £150
CA 15-3 Breast £150
CA 125 Ovary £150
CEA Stomach, Liver, Breast, Ovary, Gastrointestinal, Lung £106
CT Heart  Coronary Calcium Scoring £580

Total:  £1,136

Male Package

CA 19-9 Stomach, Colorectal, Gastrointestinal, Pancreas £150
CEA Stomach, Liver, Breast Ovary, Gastrointestinal, Lung £150
AFP Liver, Testes £100
PSA Prostate Profile £91
CT Heart Coronary Calcium Scoring £580

Total:  £1,081

Please read below more about each one of the tests included in our packages:

CA 19-9

Small increases in CA 19-9 levels can be detected in some healthy people, and in many benign conditions that affect the liver or pancreas can cause a temporary rise in CA19-9

Moderate to high levels are found in pancreatic cancer, other cancers, and in several other diseases and conditions. The highest levels of CA 19-9 are seen in a condition called excretory ductal pancreatic cancer – cancer that is found in the pancreas tissues that produce food-digesting enzymes and in the ducts that carry those enzymes into the small intestine. This tissue is where 95% of pancreatic cancers are found.

CA153 Breast Cancer Marker (Blood test)

CA 15-3 is used as a tumour marker to monitor a patient’s response to breast cancer treatment and to watch for breast cancer recurrence.

CA 15-3 is sometimes also used to give a doctor additional information about where the cancer may have spread (such as into the bones or the liver) and a general sense of how much cancer may be present.

In general, higher concentrations of CA 15-3 suggest that the breast cancer is more advanced and that a larger amount of tumour is present. The concentration of CA 15-3 tends to increase as the cancer grows. In metastatic breast cancer (cancer that has spread to other organs), the highest concentrations of CA 15-3 are often seen when the cancer has spread to the bones and/or the liver.

Mild to moderate elevations of CA 15-3 also are seen in a variety of other conditions, including liver and pancreatic cancer, cirrhosis, and benign breast disorders as well as in a certain percentage of apparently healthy individuals. The CA 15-3 elevations seen in these non-cancerous conditions tend to be stable over time.

A negative CA 15-3 result (a result below the reference range quoted by the local laboratory) cannot be used to confirm the absence of cancer in a patient. In addition, 25% to 30% of individuals with advanced breast cancer have tumours that do not produce CA 15-3.

CA125 Ovarian Cancer Marker (Blood test)

A CA125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood. CA125 is produced by some ovarian cancer cells. A very high level of CA125 may indicate that you have ovarian cancer.

However, CA125 isn’t specific to ovarian cancer and it can be raised in conditions including endometriosis, fibroids, pelvic inflammatory disease and pregnancy, so a raised CA125 level doesn’t definitely mean you have ovarian cancer.

The National Institute for Health and Care Excellence (NICE) has produced guidance that recommends testing for CA125 if you frequently experience:

  • bloating
  • feeling full quickly and/or loss of appetite
  • pelvic or abdominal pain
  • needing to urinate urgently and/or frequently

Around half of all women with early stage ovarian cancer have a raised level of CA125 in their blood. If your CA125 level is raised, you’ll be referred for an ultrasound scan.

CEA

The carcinoembryonic antigen (CEA) test measures the amount of this protein that may appear in the blood of some people who have certain kinds of cancers, especially cancer of the large intestine (colon and rectal cancer). It may also be present in people with cancer of the pancreas, breast, ovary, or lung.

Elevated levels of CEA occur when the CEA is higher than 3 ng/mL. These levels are considered abnormal. People with many types of cancers can have levels that are higher than 3 ng/mL. However, if you have values that are that high, it doesn’t necessarily mean you have cancer. Levels higher than 3 ng/mL can be found for reasons other than cancer, such as:

  • infection
  • cirrhosis of the liver
  • chronic smoking
  • inflammatory bowel disease

AFP

Liver damage and certain cancers can increase AFP concentrations significantly. This test measures the level of AFP in the blood.

AFP is produced whenever liver cells are regenerating. With chronic liver diseases, such as hepatitis and cirrhosis, AFP may be chronically elevated. Very high concentrations of AFP may be produced by certain tumours. This characteristic makes the AFP test useful as a tumor marker. Increased amounts of AFP are found in many people with a type of liver cancer called hepatocellular carcinoma and in a liver cancer occurring in infants called hepatoblastoma. They are also found in some people with cancers of the testicles or ovaries.

Coronary Artery Calcium Scoring (CACS)

CACS has been used for cardiovascular risk assessment for over 25 years and has established a role in primary cardiovascular disease (CVD) prevention. Prevention of CVD requires identification of individuals who are at greater risk of future cardiovascular problems such as heart attack and stroke, to enable effective intervention.

Lumen Diagnostics Heart Scan is the gold standard for detecting and evaluating cardiac coronary calcification, widely regarded as an indicator of heart health. An example of a disease due to calcification of the arteries would be Coronary Artery Disease (CAD). This refers to a narrowing of the coronary arteries, usually by the build-up of fatty deposits on the walls (atherosclerosis), which decreases the amount of blood that can flow through them to supply the heart. Coronary artery calcium in your blood vessels can show the presence of plaque. Plaque is a build-up of cholesterol, scar tissue and calcium. If plaque builds up in your arteries, it can narrow or block them causing CAD.

Price: £530

How to book

Appointments can be made by calling 020 7580 3145 or by sending an email to info@lumenphysicians.co.uk.